333 related articles for article (PubMed ID: 33138262)
21. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?
Peeri NC; Shrestha N; Rahman MS; Zaki R; Tan Z; Bibi S; Baghbanzadeh M; Aghamohammadi N; Zhang W; Haque U
Int J Epidemiol; 2020 Jun; 49(3):717-726. PubMed ID: 32086938
[TBL] [Abstract][Full Text] [Related]
22. From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes.
Kandeel M; Ibrahim A; Fayez M; Al-Nazawi M
J Med Virol; 2020 Jun; 92(6):660-666. PubMed ID: 32159237
[TBL] [Abstract][Full Text] [Related]
23. The novel zoonotic COVID-19 pandemic: An expected global health concern.
Contini C; Di Nuzzo M; Barp N; Bonazza A; De Giorgio R; Tognon M; Rubino S
J Infect Dev Ctries; 2020 Mar; 14(3):254-264. PubMed ID: 32235085
[TBL] [Abstract][Full Text] [Related]
24. Coronavirus infections in children: from SARS and MERS to COVID-19, a narrative review of epidemiological and clinical features.
Iannarella R; Lattanzi C; Cannata G; Argentiero A; Neglia C; Fainardi V; Pisi G; Esposito S
Acta Biomed; 2020 Sep; 91(3):e2020032. PubMed ID: 32921726
[TBL] [Abstract][Full Text] [Related]
25. Susceptibility to SARS, MERS, and COVID-19 from animal health perspective.
Gautam A; Kaphle K; Shrestha B; Phuyal S
Open Vet J; 2020 Aug; 10(2):164-177. PubMed ID: 32821661
[TBL] [Abstract][Full Text] [Related]
26. Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020.
Riou J; Althaus CL
Euro Surveill; 2020 Jan; 25(4):. PubMed ID: 32019669
[TBL] [Abstract][Full Text] [Related]
27. Three Emerging Coronaviruses in Two Decades.
Guarner J
Am J Clin Pathol; 2020 Mar; 153(4):420-421. PubMed ID: 32053148
[No Abstract] [Full Text] [Related]
28. Seasonality of Respiratory Viral Infections.
Moriyama M; Hugentobler WJ; Iwasaki A
Annu Rev Virol; 2020 Sep; 7(1):83-101. PubMed ID: 32196426
[TBL] [Abstract][Full Text] [Related]
29. The effect of coronavirus infection (SARS-CoV-2, MERS-CoV, and SARS-CoV) during pregnancy and the possibility of vertical maternal-fetal transmission: a systematic review and meta-analysis.
Diriba K; Awulachew E; Getu E
Eur J Med Res; 2020 Sep; 25(1):39. PubMed ID: 32887660
[TBL] [Abstract][Full Text] [Related]
30. Tuberculosis and COVID-19: Lessons from the Past Viral Outbreaks and Possible Future Outcomes.
Crisan-Dabija R; Grigorescu C; Pavel CA; Artene B; Popa IV; Cernomaz A; Burlacu A
Can Respir J; 2020; 2020():1401053. PubMed ID: 32934758
[TBL] [Abstract][Full Text] [Related]
31. Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 in Aerosol Suspensions.
Fears AC; Klimstra WB; Duprex P; Hartman A; Weaver SC; Plante KS; Mirchandani D; Plante JA; Aguilar PV; Fernández D; Nalca A; Totura A; Dyer D; Kearney B; Lackemeyer M; Bohannon JK; Johnson R; Garry RF; Reed DS; Roy CJ
Emerg Infect Dis; 2020 Sep; 26(9):2168-71. PubMed ID: 32568661
[TBL] [Abstract][Full Text] [Related]
32. What Have Hospital Social Workers Been Prepared for COVID-19 from SARS, MERS, and H1N1?
Cheung JC
Health Soc Work; 2020 Aug; 45(3):211-214. PubMed ID: 32712667
[No Abstract] [Full Text] [Related]
33. From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses.
Zhu Z; Lian X; Su X; Wu W; Marraro GA; Zeng Y
Respir Res; 2020 Aug; 21(1):224. PubMed ID: 32854739
[TBL] [Abstract][Full Text] [Related]
34. Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV.
Meo SA; Alhowikan AM; Al-Khlaiwi T; Meo IM; Halepoto DM; Iqbal M; Usmani AM; Hajjar W; Ahmed N
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):2012-2019. PubMed ID: 32141570
[TBL] [Abstract][Full Text] [Related]
35. Glucovigilance in COVID-19.
Lamptey R; Ahomagnon S; Acheampong F; Kalra S
J Pak Med Assoc; 2020 May; 70(Suppl 3)(5):S80-S82. PubMed ID: 32515386
[TBL] [Abstract][Full Text] [Related]
36. Preparation for Possible Sustained Transmission of 2019 Novel Coronavirus: Lessons From Previous Epidemics.
Swerdlow DL; Finelli L
JAMA; 2020 Mar; 323(12):1129-1130. PubMed ID: 32207807
[No Abstract] [Full Text] [Related]
37. [Management guidelines for vulnerable workers and persons and SARS-CoV-2 in Catalonian businesses].
Grupo de trabajo Grupo de trabajo para la elaboración de criterios para la gestión de personas especialmente vulnerables y trabajadores/as especialmente sensibles frente al SARS-CoV-2 en las empresas de Cataluña.GTPSVTESSARS-CoV-2
Arch Prev Riesgos Labor; 2020 Apr; 23(2):234-252. PubMed ID: 32320546
[No Abstract] [Full Text] [Related]
38. Effects of the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) on the nervous system. What can we expect from SARS -CoV-2?
Monroy-Gómez J; Torres-Fernández O
Biomedica; 2020 Oct; 40(Supl. 2):173-179. PubMed ID: 33152201
[TBL] [Abstract][Full Text] [Related]
39. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a newly emerged pathogen: an overview.
Rathore JS; Ghosh C
Pathog Dis; 2020 Aug; 78(6):. PubMed ID: 32840560
[TBL] [Abstract][Full Text] [Related]
40. Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks.
Wooding DJ; Bach H
Clin Microbiol Infect; 2020 Oct; 26(10):1436-1446. PubMed ID: 32791241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
